Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes


Por: Bertholet J, Anastasi G, Noble D, Bel A, van Leeuwen R, Roggen T, Duchateau M, Pilskog S, Garibaldi C, Tilly N, Garcia-Molla R, Bonaque J, Oelfke U, Aznar M, Ben Heijmen

Publicada: 1 dic 2020
Resumen:
Purpose: The POP-ART RT study aims to determine to what extent and how intrafractional real-time respiratory motion management (RRMM), and plan adaptation for interfractional anatomical changes (ART) are used in clinical practice and to understand barriers to implementation. Here we report on part II: ART using more than one plan per target per treatment course. Materials and methods: A questionnaire on the current practice of ART, wishes for expansion or implementation, and barriers to implementation was distributed worldwide. Four types of ART were discriminated: daily online replanning, online plan library, protocolled offline replanning (all three based on a protocol), and ad-hoc offline replanning. Results: The questionnaire was completed by 177 centres from 40 countries. ART was used by 61% of respondents (31% with protocol) for a median (range) of 3 (1-8) tumour sites. CBCT/MVCT was the main imaging modality except for online daily replanning (11 users) where 10 users used MR. Two thirds of respondents wished to implement ART for a new tumour site; 40% of these had plans to do it in the next 2 years. Human/material resources and technical limitations were the main barriers to further use and implementation. Conclusions: ART was used for a broad range of tumour sites, mainly with ad-hoc offline replanning and for a median of 3 tumour sites. There was a large interest in implementing ART for more tumour sites, mainly limited by human/material resources and technical limitations. Daily online replanning was primarily performed on MR-linacs. (C) 2020 The Authors. Published by Elsevier B.V.

Filiaciones:
Bertholet J:
 Inst Canc Res, Joint Dept Phys, London, England

 Royal Marsden NHS Fdn Trust, London, England

 Univ Bern, Bern Univ Hosp, Inselspital, Dept Radiat Oncol,Div Med Radiat Phys, CH-3010 Bern, Switzerland

Anastasi G:
 Royal Surrey Cty Hosp, Dept Med Phys, St Lukes Canc Ctr, Guildford, Surrey, England

Noble D:
 Univ Cambridge, Canc Res UK VoxTox Res Grp, Addenbrookes Hosp, Cambridge Biomed Campus, Cambridge, England

Bel A:
 Amsterdam UMC, Dept Radiat Oncol, Nijmegen, Netherlands

van Leeuwen R:
 Radboud Univ Nijmegen Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands

Roggen T:
 Varian Med Syst Imaging Lab GmbH, Appl Res, Dattwil, Switzerland

Duchateau M:
 MIM Software Inc, Cleveland, OH USA

Pilskog S:
 Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway

 Univ Bergen, Dept Phys & Technol, Bergen, Norway

Garibaldi C:
 European Inst Oncol IRCCS, Unit Radiat Res, IEO, Milan, Italy

Tilly N:
 Elekta Instruments AB, Stockholm, Sweden

 Uppsala Univ, Dept Immunol Genet & Pathol, Med Radiat Phys, Uppsala, Sweden

Garcia-Molla R:
 Consorcio Hosp Gen Univ Valencia, Serv Radiofis & Protecc Radiol, Valencia, Spain

Bonaque J:
 Consorcio Hosp Prov Castellon, Serv Radiofis & Protecc Radiol, Castellon De La Plana, Spain

Oelfke U:
 Inst Canc Res, Joint Dept Phys, London, England

 Royal Marsden NHS Fdn Trust, London, England

Aznar M:
 Univ Manchester, Div Canc Sci, Fac Biol Med & Hlth, Christie NHS Fdn Trust, Manchester, Lancs, England

 Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England

Ben Heijmen:
 Erasmus MC Canc Inst, Dept Radiat Oncol, Rotterdam, Netherlands
ISSN: 01678140





Radiotherapy And Oncology
Editorial
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND, Irlanda
Tipo de documento: Article
Volumen: 153 Número:
Páginas: 88-96
WOS Id: 000600731700011
ID de PubMed: 32579998

MÉTRICAS